Analysts with bull ratings on athenahealth, Inc (NASDAQ:ATHN) are rushing to the company's defense after David Einhorn's very public short attack. Baird's latest report defends athenahealth's growth targets vehemently while reducing their price target to $175. The report explains that the change in PT has nothing to do with the short seller's comments and is only based on industry multiples, which have compressed dramatically in the past months. Baird is bullish on athena and believes that it will go on to become much bigger and more successful over the years.
Athena was recently given five awards by KLAS and crowned as best...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full ArticleAlready a member? Log in here
